Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,289Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M115EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)19.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28,650,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IBB is held by these investors:



IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.482951.9view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.941607.91view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2017-01-16Buy4,000$0.17170088.24view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.3621173.53view
Bebek, IvanDirector 2017-01-16Buy8,990$3.388459.76view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4170465.85view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91936.62view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.274514.35view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38379.17view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.15192780view

Press Releases about IBB :

Quarterly/Annual Reports about IBB:

    News about IBB:

    Articles On GuruFocus.com
    Easy and Practical Framework to Invest Like Buffett and Beyond Feb 23 2017 
    David Einhorn: Trump Bringing Inflation, ‘High Degree’ of Uncertainty Feb 23 2017 
    Trump's Tax Policy May Make for Some Very Easy Investing Feb 23 2017 
    Dividend Aristocrat on the Rebound Feb 23 2017 
    Is Nu Skin's 11% Earnings Drop an Overreaction? Feb 23 2017 
    Weekly CFO Buys Highlights Feb 23 2017 
    Weekly CFO Sells Highlights Feb 23 2017 
    Aytu BioScience's Natesto to Target Low Testosterone Feb 23 2017 
    Canadian Auto Parts Manufacturer Is on Sale Feb 23 2017 
    Beat the Market With a Water ETF Feb 23 2017 

    More From Other Websites
    Barron's Picks And Pans: General Motors, Hess, Biotechs And More Feb 19 2017
    Stock Market Video Analysis 2/17/17 Feb 17 2017
    Biotech ETF Investors are Still on the Sidelines Feb 17 2017
    Biotech boom? Feb 15 2017
    Stock Market Video Analysis 2/15/17 Feb 15 2017
    Two Great Stock Ideas in the IBB Biotech ETF Feb 15 2017
    The New Normal: Is The Current Bull Market Trump Resistant? Feb 14 2017
    Final Trade: QCOM, TWTR & more Feb 13 2017
    Gilead tanks on weak forecast Feb 08 2017
    How To Maximize Biotech Returns Under Donald Trump Feb 08 2017
    Healthcare Stocks: The Buying Opportunity of the Year? Feb 07 2017
    White House says Trump wants Medicare negotiation on drug... Feb 07 2017
    Buy safety in sideways tape? Feb 06 2017
    Priced like an automaker, sputtering Gilead shares lure value bets Feb 06 2017
    Amgen: Who Says Biotech's Dead? Feb 03 2017
    How to trade Amgen/Amazon earnings: 5 trades Feb 02 2017
    Making pharma great again? Jan 31 2017
    Not all bad news with Trump pharma meeting? Jan 31 2017
    Klain: Pharma will be net winner in exchange with Trump a... Jan 31 2017
    What Lies Ahead for Biotech ETFs in Trump Era? Jan 27 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)